These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33386220)

  • 1. Efficacy of Diffusion-Weighted Imaging in Neoadjuvant Chemotherapy for Osteosarcoma: A Systematic Review and Meta-Analysis.
    Yuan W; Yu Q; Wang Z; Huang J; Wang J; Long L
    Acad Radiol; 2022 Feb; 29(2):326-334. PubMed ID: 33386220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
    Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
    Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
    Habre C; Dabadie A; Loundou AD; Banos JB; Desvignes C; Pico H; Aschero A; Colavolpe N; Seiler C; Bouvier C; Peltier E; Gentet JC; Baunin C; Auquier P; Petit P
    Pediatr Radiol; 2021 Aug; 51(9):1714-1723. PubMed ID: 33877417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.
    Lee SK; Jee WH; Jung CK; Im SA; Chung NG; Chung YG
    PLoS One; 2020; 15(3):e0229983. PubMed ID: 32155203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
    Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
    PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of diffusion-weighted imaging for evaluating chemotherapy response in osteosarcoma: A meta-analysis.
    Kubo T; Furuta T; Johan MP; Ochi M; Adachi N
    Mol Clin Oncol; 2017 Jul; 7(1):88-92. PubMed ID: 28685082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience.
    Asmar K; Saade C; Salman R; Saab R; Khoury NJ; Abboud M; Tamim H; Makki M; Naffaa L
    Eur J Radiol; 2020 Mar; 124():108855. PubMed ID: 32018075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
    Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
    Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
    Liu C; Xi Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
    Korean J Radiol; 2019 May; 20(5):801-811. PubMed ID: 30993931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis.
    Bilreiro C; Andrade L; Marques RM; Matos C
    Eur Radiol; 2024 May; 34(5):3238-3248. PubMed ID: 37907761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of apparent diffusion coefficient combined with serum tumor markers detection in evaluating neoadjuvant chemotherapy for osteosarcoma].
    Wang Z; Liu L; Song YX; Zhang H; She W; Qian YW
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1012-1016. PubMed ID: 32294859
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.
    Oka K; Yakushiji T; Sato H; Hirai T; Yamashita Y; Mizuta H
    Skeletal Radiol; 2010 Feb; 39(2):141-6. PubMed ID: 19924412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive intravoxel incoherent motion MRI in prediction of histopathological response to neoadjuvant chemotherapy and survival outcome in osteosarcoma at the time of diagnosis.
    Baidya Kayal E; Bakhshi S; Kandasamy D; Sharma MC; Khan SA; Kumar VS; Khare K; Sharma R; Mehndiratta A
    J Transl Med; 2022 Dec; 20(1):625. PubMed ID: 36575510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
    Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
    BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-Based Apparent Diffusion Coefficient for Predicting Pathologic Response of Rectal Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis.
    Amodeo S; Rosman AS; Desiato V; Hindman NM; Newman E; Berman R; Pachter HL; Melis M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W205-W216. PubMed ID: 30240291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.
    Baunin C; Schmidt G; Baumstarck K; Bouvier C; Gentet JC; Aschero A; Ruocco A; Bourlière B; Gorincour G; Desvignes C; Colavolpe N; Bollini G; Auqier P; Petit P
    Skeletal Radiol; 2012 Sep; 41(9):1141-9. PubMed ID: 22318350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
    Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
    Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
    Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
    Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
    Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
    NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.